Table of Contents
ISRN Cardiology
Volume 2011 (2011), Article ID 457247, 5 pages
http://dx.doi.org/10.5402/2011/457247
Review Article

Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy

1Abteilung für Kardiologie und Kreislauferkrankungen, Klinikum der Eberhard-Karls-Universität Tübingen, 72076 Tübingen, Germany
2Klinik und Poliklinik für Innere Medizin B, Klinikum der Ernst-Moritz-Arndt-Universität Greifswald 17475 Greifswald, Germany

Received 20 February 2011; Accepted 8 April 2011

Academic Editors: M. Fito Colomer, L. Liaudet, and P. Meier

Copyright © 2011 Roman Laszlo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. G. Priori, E. Aliot, C. Blomstrom-Lundqvist et al., “Task Force on sudden cardiac death of the European Society of Cardiology,” European Heart Journal, vol. 22, no. 16, pp. 1374–1450, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. Mirowski, M. M. Mower, and P. R. Reid, “The automatic implantable defibrillator,” American Heart Journal, vol. 100, no. 6, part 2, pp. 1089–1092, 1980. View at Google Scholar · View at Scopus
  3. D. P. Zipes et al., “ACC/AHA/ESC guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society,” European Heart Journal, vol. 27, no. 17, pp. 2099–2140, 2006. View at Google Scholar
  4. J. J. Goldberger, M. E. Cain, S. H. Hohnloser et al., “American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention,” Heart Rhythm, vol. 5, no. 10, pp. e1–e21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. S. Chugh, J. Jui, K. Gunson et al., “Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community,” Journal of the American College of Cardiology, vol. 44, no. 6, pp. 1268–1275, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. J. Podrid and R. J. Myerburg, “Epidemiology and stratification of risk for sudden cardiac death,” Clinical Cardiology, vol. 28, no. 11, supplement 1, pp. I3–I11, 2005. View at Google Scholar · View at Scopus
  7. M. Rubart and D. P. Zipes, “Mechanisms of sudden cardiac death,” Journal of Clinical Investigation, vol. 115, no. 9, pp. 2305–2315, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. Engdahl, M. Holmberg, B. W. Karlson, R. Luepker, and J. Herlitz, “The epidemiology of out-of-hospital 'sudden' cardiac arrest,” Resuscitation, vol. 52, no. 3, pp. 235–245, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Wit and M. J. Janse, “Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction,” Circulation, vol. 85, supplement 1, pp. I32–I42, 1992. View at Google Scholar · View at Scopus
  10. S. M. Pogwizd and P. B. Corr, “Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia,” Circulation Research, vol. 66, no. 3, pp. 672–695, 1990. View at Google Scholar · View at Scopus
  11. T. Takahashi, P. van Dessel, J. C. Lopshire et al., “Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction,” Heart Rhythm, vol. 1, no. 4, pp. 451–459, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. W. G. Stevenson, L. W. Stevenson, H. R. Middlekauff, and L. A. Saxon, “Sudden death prevention in patients with advanced ventricular dysfunction,” Circulation, vol. 88, no. 6, pp. 2953–2961, 1993. View at Google Scholar · View at Scopus
  13. D. S. Echt, P. R. Liebson, L. B. Mitchell et al., “Mortality and morbidity in patients receiving encainide, flecainide, or placebo—the Cardiac Arrhythmia Suppression Trial,” The New England Journal of Medicine, vol. 324, no. 12, pp. 781–788, 1991. View at Google Scholar · View at Scopus
  14. A. J. Moss et al., “Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators,” The New England Journal of Medicine, vol. 335, no. 26, pp. 1933–1940, 1996. View at Google Scholar
  15. D. G. Wyse, M. Talajic, G. E. Hafley et al., “Antiarrhythmic drug therapy in the Multicenter Unsustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis,” Journal of the American College of Cardiology, vol. 38, no. 2, pp. 344–351, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. G. H. Bardy, K. L. Lee, D. B. Mark et al., “Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure,” The New England Journal of Medicine, vol. 352, no. 3, pp. 225–237, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. N. Sotoodehnia, A. Zivin, G. H. Bardy, and D. S. Siscovick, “Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research,” Cardiovascular Research, vol. 50, no. 2, pp. 197–209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bauer, J. W. Kantelhardt, P. Barthel et al., “Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study,” The Lancet, vol. 367, no. 9523, pp. 1674–1681, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. D. V. Exner, K. M. Kavanagh, M. P. Slawnych et al., “Noninvasive risk assessment early after a myocardial infarction. The REFINE study,” Journal of the American College of Cardiology, vol. 50, no. 24, pp. 2275–2284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. T. H. Mäkikallio, P. Barthel, R. Schneider et al., “Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era,” European Heart Journal, vol. 26, no. 8, pp. 762–769, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. J. Moss, W. Zareba, W. Jackson Hall et al., “Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction,” The New England Journal of Medicine, vol. 346, no. 12, pp. 877–883, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. Kadish, A. Dyer, J. P. Daubert et al., “Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy,” The New England Journal of Medicine, vol. 350, no. 21, pp. 2151–2158, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. Wolpert, J. Kuschyk, N. Aramin et al., “Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator,” Heart, vol. 90, no. 6, pp. 667–671, 2004. View at Google Scholar · View at Scopus
  24. M. R. Reynolds, D. J. Cohen, A. D. Kugelmass et al., “The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators,” Journal of the American College of Cardiology, vol. 47, no. 12, pp. 2493–2497, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Tung, P. Zimetbaum, and M. E. Josephson, “A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death,” Journal of the American College of Cardiology, vol. 52, no. 14, pp. 1111–1121, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Kowalski, J. F. Huizar, K. Kaszala, and M. A. Wood, “Problems with implantable cardiac device therapy,” Cardiology Clinics, vol. 26, no. 3, pp. 441–458, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. T. W. Smith and M. E. Cain, “Sudden cardiac death: epidemiologic and financial worldwide perspective,” Journal of Interventional Cardiac Electrophysiology, vol. 17, no. 3, pp. 199–203, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. D. Farwell and M. H. Gollob, “Risk stratification for sudden death in heart failure,” Minerva Cardioangiologica, vol. 55, no. 3, pp. 379–384, 2007. View at Google Scholar · View at Scopus
  29. G. A. Lanza, “The electrocardiogram as a prognostic tool for predicting major cardiac events,” Progress in Cardiovascular Diseases, vol. 50, no. 2, pp. 87–111, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. L. Kusmirek and M. R. Gold, “Sudden cardiac death: the role of risk stratification,” American Heart Journal, vol. 153, no. 4, supplement, pp. 25–33, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. R. Villuendas and A. H. Kadish, “Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed,” Progress in Cardiovascular Diseases, vol. 51, no. 2, pp. 128–134, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. R. Berger, M. Huelsman, K. Strecker et al., “B-type natriuretic peptide predicts sudden death in patients with chronic heart failure,” Circulation, vol. 105, no. 20, pp. 2392–2397, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Blangy, N. Sadoul, B. Dousset et al., “Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction,” Europace, vol. 9, no. 9, pp. 724–729, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. W. Jung, D. Andresen, M. Block et al., “Guidelines for implantation of defibrillators,” Clinical Research in Cardiology, vol. 95, no. 12, pp. 696–708, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. X. Jouven, M. Desnos, C. Guerot, and P. Ducimetière, “Predicting sudden death in the population. The Paris prospective study I,” Circulation, vol. 99, no. 15, pp. 1978–1983, 1999. View at Google Scholar · View at Scopus
  36. Y. Friedlander, D. S. Siscovick, P. Arbogast et al., “Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest,” Atherosclerosis, vol. 162, no. 1, pp. 211–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Friedlander, D. S. Siscovick, S. Weinmann et al., “Family history as a risk factor for primary cardiac arrest,” Circulation, vol. 97, no. 2, pp. 155–160, 1998. View at Google Scholar · View at Scopus
  38. L. R. C. Dekker, C. R. Bezzina, J. P. S. Henriques et al., “Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients,” Circulation, vol. 114, no. 11, pp. 1140–1145, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. P. M. Elliott, J. Poloniecki, S. Dickie et al., “Sudden death in hypertrophic cardiomyopathy: identification of high risk patients,” Journal of the American College of Cardiology, vol. 36, no. 7, pp. 2212–2218, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. P. M. Spooner, C. Albert, E. J. Benjamin et al., “Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part II,” Circulation, vol. 103, no. 20, pp. 2447–2452, 2001. View at Google Scholar · View at Scopus
  41. P. M. Spooner, C. Albert, E. J. Benjamin et al., “Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, part I,” Circulation, vol. 103, no. 19, pp. 2361–2364, 2001. View at Google Scholar · View at Scopus
  42. J. M. Prutkin and N. Sotoodehnia, “Genetics of sudden cardiac arrest,” Progress in Cardiovascular Diseases, vol. 50, no. 6, pp. 390–403, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. C. Levin, S. Marullo, O. Muntaner, B. Andersson, and Y. Magnusson, “The myocardium-protective Gly-49 variant of the β-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation,” Journal of Biological Chemistry, vol. 277, no. 34, pp. 30429–30435, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. K. Ranade, E. Jorgenson, W. H. H. Sheu et al., “A polymorphism in the β1 adrenergic receptor is associated with resting heart rate,” American Journal of Human Genetics, vol. 70, no. 4, pp. 935–942, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. M. Borjesson, Y. Magnusson, A. Hjalmarson, and B. Andersson, “A novel polymorphism in the gene coding for the beta-adrenergic receptor associated with survival in patients with heart failure,” European Heart Journal, vol. 21, no. 22, pp. 1853–1858, 2000. View at Google Scholar · View at Scopus
  46. D. A. Mason, J. D. Moore, S. A. Green, and S. B. Liggett, “A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor,” Journal of Biological Chemistry, vol. 274, no. 18, pp. 12670–12674, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Iwai, A. Hozuka, S. Nobuyuki et al., “Suppressive effect of the Gly389 allele of the β1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy,” Circulation Journal, vol. 66, no. 8, pp. 723–728, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. J. D. Blumenfeld, J. E. Sealey, S. J. Mann et al., “β-Adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects,” American Journal of Hypertension, vol. 12, no. 5, pp. 451–459, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. S. Bedi, L. A. Postava, S. Murali et al., “Interaction of implantable defibrillator therapy with angiotensin- converting enzyme deletion/insertion polymorphism,” Journal of Cardiovascular Electrophysiology, vol. 15, no. 10, pp. 1162–1166, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus